Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 A contemporary approach to hypertrophic cardiomyopathy.

× No keyword cloud information.

40 in total

1. Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy.

Authors: Neal K Lakdawala; Lisa Dellefave; Charles S Redwood; Elizabeth Sparks; Allison L Cirino; Steve Depalma; Steven D Colan; Birgit Funke; Rebekah S Zimmerman; Paul Robinson; Hugh Watkins; Christine E Seidman; J G Seidman; Elizabeth M McNally; Carolyn Y Ho
Journal: J Am Coll Cardiol Date: 2010-01-26 Impact factor: 24.094

Review 2. Cardiovascular genetic medicine: evolving concepts, rationale, and implementation.

Authors: Ray E Hershberger
Journal: J Cardiovasc Transl Res Date: 2008-05-20 Impact factor: 4.132

3. Mutations in NEXN, a Z-disc gene, are associated with hypertrophic cardiomyopathy.

Authors: Hu Wang; Zhaohui Li; Jizheng Wang; Kai Sun; Qiqiong Cui; Lei Song; Yubao Zou; Xiaojian Wang; Xuan Liu; Rutai Hui; Yuxin Fan
Journal: Am J Hum Genet Date: 2010-10-21 Impact factor: 11.025

Review 4. Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.

Authors: Iacopo Olivotto; Franco Cecchi; Corrado Poggesi; Magdi H Yacoub
Journal: Nat Rev Cardiol Date: 2009-04 Impact factor: 32.419

Review 5. Clinical screening and genetic testing.

Authors: Rahul C Deo; Calum A MacRae
Journal: Heart Fail Clin Date: 2010-04 Impact factor: 3.179

6. Enhanced active cross-bridges during diastole: molecular pathogenesis of tropomyosin's HCM mutations.

Authors: Fan Bai; Adam Weis; Aya K Takeda; P Bryant Chase; Masataka Kawai
Journal: Biophys J Date: 2011-02-16 Impact factor: 4.033

7. The effects of candesartan on left ventricular hypertrophy and function in nonobstructive hypertrophic cardiomyopathy: a pilot, randomized study.

Authors: Martin Penicka; Pavel Gregor; Roman Kerekes; Dan Marek; Karol Curila; Jiri Krupicka
Journal: J Mol Diagn Date: 2008-12-12 Impact factor: 5.568

Review 8. Vinculin and talin: focus on the myocardium.

Authors: Alice Zemljic-Harpf; Ana Maria Manso; Robert S Ross
Journal: J Investig Med Date: 2009-12 Impact factor: 2.895

9. Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

Authors: I A W van Rijsingen; J F Hermans-van Ast; Y H J M Arens; S M Schalla; C E M de Die-Smulders; A van den Wijngaard; Y M Pinto
Journal: Neth Heart J Date: 2009-12 Impact factor: 2.380

Review 10. A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management.

Authors: Kyla E Dunn; Colleen Caleshu; Allison L Cirino; Carolyn Y Ho; Euan A Ashley
Journal: Circ Cardiovasc Genet Date: 2013-02